Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fernando Rizzello

Showing results (111-120 of 138) with videos related to

Pageof 14
Sort By:
Frontiers in Immunology|March 13, 2024
Corrigendum: Poor prognostic factors of pharmacokinetic origin predict outcomes in inflammatory bowel disease patients treated with anti-tumor necrosis factor-αElizabeth A Spencer, Marla C Dubinsky, Michael A Kamm, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|March 4, 2017
Use of corticosteroids and immunosuppressive drugs in inflammatory bowel disease: Clinical practice guidelines of the Italian Group for the Study of Inflammatory Bowel DiseasePaolo Gionchetti, Fernando Rizzello, Vito Annese, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|January 16, 2021
COVID-19 in IBD: The experience of a single tertiary IBD centerFernando Rizzello, Carlo Calabrese, Marco Salice, et al.
Journal of Crohn'S & Colitis|April 29, 2017
Training Programs on Endoscopic Scoring Systems for Inflammatory Bowel Disease Lead to a Significant Increase in Interobserver Agreement Among Community GastroenterologistsMarco Daperno, Michele Comberlato, Fabrizio Bossa, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|June 14, 2021
Female reproductive health and inflammatory bowel disease: A practice-based review, Alessandro Armuzzi, Aurora Bortoli, et al.
Journal of Crohn'S & Colitis|August 18, 2023
Adalimumab Clearance, Rather Than Trough Level, May Have Greatest Relevance to Crohn's Disease Therapeutic Outcomes Assessed Clinically and EndoscopicallyEmily K Wright, Maria Chaparro, Paolo Gionchetti, et al.
Inflammatory Bowel Diseases|July 14, 2021
COVID-19 Vaccination Willingness and Hesitancy in Patients With Inflammatory Bowel Diseases: Analysis of Determinants in a National Survey of the Italian IBD Patients' AssociationAndrea Costantino, Daniele Noviello, Francesco Simone Conforti, et al.
Autoimmunity Reviews|April 29, 2026
Dynamic profiling in inflammatory Bowel disease: A manifesto for personalized careGiuseppe Privitera, Mariangela Allocca, Luca Antonioli, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|December 10, 2023
Transition care in patients with IBD: The pediatric and the adult gastroenterologist's perspective. Results from a national surveyFabiana Castiglione, Luca Scarallo, Olga Maria Nardone, et al.
Autoimmunity Reviews|June 4, 2026
Corrigendum to 'Dynamic profiling in inflammatory Bowel disease: A manifesto for personalized care' [Autoimmunity Reviews 25 (2026) 104068]Giuseppe Privitera, Mariangela Allocca, Luca Antonioli, et al.
Pageof 14

Showing results (111-120 of 138) with videos related to

Sort By:
Pageof 14
Frontiers in Immunology|March 13, 2024
Corrigendum: Poor prognostic factors of pharmacokinetic origin predict outcomes in inflammatory bowel disease patients treated with anti-tumor necrosis factor-αElizabeth A Spencer, Marla C Dubinsky, Michael A Kamm, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|March 4, 2017
Use of corticosteroids and immunosuppressive drugs in inflammatory bowel disease: Clinical practice guidelines of the Italian Group for the Study of Inflammatory Bowel DiseasePaolo Gionchetti, Fernando Rizzello, Vito Annese, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|January 16, 2021
COVID-19 in IBD: The experience of a single tertiary IBD centerFernando Rizzello, Carlo Calabrese, Marco Salice, et al.
Journal of Crohn'S & Colitis|April 29, 2017
Training Programs on Endoscopic Scoring Systems for Inflammatory Bowel Disease Lead to a Significant Increase in Interobserver Agreement Among Community GastroenterologistsMarco Daperno, Michele Comberlato, Fabrizio Bossa, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|June 14, 2021
Female reproductive health and inflammatory bowel disease: A practice-based review, Alessandro Armuzzi, Aurora Bortoli, et al.
Journal of Crohn'S & Colitis|August 18, 2023
Adalimumab Clearance, Rather Than Trough Level, May Have Greatest Relevance to Crohn's Disease Therapeutic Outcomes Assessed Clinically and EndoscopicallyEmily K Wright, Maria Chaparro, Paolo Gionchetti, et al.
Inflammatory Bowel Diseases|July 14, 2021
COVID-19 Vaccination Willingness and Hesitancy in Patients With Inflammatory Bowel Diseases: Analysis of Determinants in a National Survey of the Italian IBD Patients' AssociationAndrea Costantino, Daniele Noviello, Francesco Simone Conforti, et al.
Autoimmunity Reviews|April 29, 2026
Dynamic profiling in inflammatory Bowel disease: A manifesto for personalized careGiuseppe Privitera, Mariangela Allocca, Luca Antonioli, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|December 10, 2023
Transition care in patients with IBD: The pediatric and the adult gastroenterologist's perspective. Results from a national surveyFabiana Castiglione, Luca Scarallo, Olga Maria Nardone, et al.
Autoimmunity Reviews|June 4, 2026
Corrigendum to 'Dynamic profiling in inflammatory Bowel disease: A manifesto for personalized care' [Autoimmunity Reviews 25 (2026) 104068]Giuseppe Privitera, Mariangela Allocca, Luca Antonioli, et al.
Pageof 14